Theodore J. Witek, Jr
2015
In 2015, Theodore J. Witek, Jr earned a total compensation of $1.6M as Senior Vice President and Chief Scientific Officer Clinical and Medical Affairs at Innoviva, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,857 |
|---|---|
| Salary | $407,105 |
| Stock Awards | $938,934 |
| Other | $12,000 |
| Total | $1,551,896 |
Witek received $938.9K in stock awards, accounting for 61% of the total pay in 2015.
Witek also received $193.9K in non-equity incentive plan, $407.1K in salary and $12K in other compensation.
Rankings
In 2015, Theodore J. Witek, Jr's compensation ranked 5,826th out of 13,638 executives tracked by ExecPay. In other words, Witek earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,826 out of 13,638 | 57th |
Division Manufacturing | 2,172 out of 5,187 | 58th |
Major group Chemicals And Allied Products | 783 out of 1,857 | 58th |
Industry group Drugs | 624 out of 1,531 | 59th |
Industry Pharmaceutical Preparations | 489 out of 1,179 | 59th |
Source: SEC filing on March 25, 2016.
Witek's colleagues
We found four more compensation records of executives who worked with Theodore J. Witek, Jr at Innoviva in 2015.